European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

Marko Babjuk , Maximilian Burger , Éva Compérat , Marko Babjuk , Maximilian Burger , Éva Compérat , Paolo Gontero , Hugh Mostafid , Joan Palou , Bas W.G. van Rhijn , Morgan Rouprêt , Shahrokh F. Shariat , Richard Sylvester , Richard Zigeuner , Otakar Čapoun , Daniel L. Cohen , J.L. Domínguez Escrig , Virginia Hernández , B. Peyronnet , Thomas Seisen , Viktor Soukup
2019 European Urology 1,261 citations

Keywords

MedicineCystoscopyBladder cancerCarcinoma in situUrologyMEDLINECarcinomaCancerInternal medicineOncologyUrinary system

Affiliated Institutions

Related Publications

Bladder Cancer

Andrew T. Lenis , Patrick M. Lec , Karim Chamie +1 more

Improved understanding of the molecular biology and genetics of bladder cancer has evolved the way localized and advanced disease is diagnosed and treated. While intravesical BC...

2020 JAMA 1621 citations

Publication Info

Year
2019
Type
review
Volume
76
Issue
5
Pages
639-657
Citations
1261
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1261
OpenAlex

Cite This

Marko Babjuk, Maximilian Burger, Éva Compérat et al. (2019). European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. European Urology , 76 (5) , 639-657. https://doi.org/10.1016/j.eururo.2019.08.016

Identifiers

DOI
10.1016/j.eururo.2019.08.016